Stablix Therapeutics

Last updated: October 06, 2024

CEO - Clare Ozawa
CEO - Clare Ozawa
USA | Funding: $63M (+)

Website: https://www.stablix.com/

Stablix Therapeutics, a biotechnology company pioneering the Targeted Protein Stabilization technologies that is used to cure cystic fibrosis and cancer